CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Costs Associated With Diabetes Among Adult Medicaid Enrollees

Published: Thu, 18 Oct 2018 12:00:00 EDT
This report details state-specific financial burdens of diabetes in the Medicaid population of eight states.
Preventing Chronic Disease

FDA Panel Oks Tegaserod for IBS-C in Women with Low CV Risk

Published: Wed, 17 Oct 2018 19:41:59 EDT
The Gastrointestinal Drugs Advisory Committee of the FDA recommended reintroducing tegaserod maleate for women with irritable bowel syndrome and low cardiovascular risk.
Medscape Medical News
Displaying results 19-20 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

‘Retina in a dish’ provides new insight into inherited blindness

Published: Fri, 12 Oct 2018 16:59:27 +0000
Mutations in cell proteins known as “splicing factors” can cause the eye disease retinitis pigmentosa, though the exact mechanism behind the problem has been somewhat of a mystery. Scientists at Newcastle University demonstrated that defective splicing factors are unable to correctly proofread the genetic code of retinal cells, resulting in a progressive loss of sight.

Adynxx merges with Alliqua, snagging Nasdaq listing ahead of pain trials

Published: Fri, 12 Oct 2018 12:25:26 +0000
Adynxx is set to gain a Nasdaq listing by merging with Alliqua BioMedical. The reverse merger comes six months after Adynxx committed to advancing pain drug brivoligide, despite the candidate coming up short in a midphase study.

Hoth Therapeutics seeks IPO cash to battle eczema

Published: Fri, 12 Oct 2018 10:07:35 +0000
Hoth Therapeutics has filed to raise around $11 million in a Nasdaq IPO. The tiny offering will equip Hoth to test a topical formulation of the broad-spectrum antibiotic gentamicin in a phase 2 eczema trial.
Displaying results 22-24 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top